Ahmet Davut Aksu: Next Generation Fibrinolysis with Improved Selectivity and Resistance
Ahmet Davut Aksu, Researcher at University of Masarykova, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in ACS Catalysis, adding:
“I am happy to share our new publication, which presents a multi-objective engineering strategy designed to optimize fibrinolytic efficacy, fibrin selectivity, and inhibition resistance within a single workflow.
The lead variant produced under this approach, Brnoteplase, demonstrated improved fibrin selectivity, resistance to inhibiton, and elevated clot penetration, together extending the effective catalytic lifetime and enabling bolus administration.”
Title: Multiobjective Engineering of Fibrin-Selective Thrombolytic Proteases with Enhanced Biocatalytic Efficiency and Inhibition Resistance
Authors: Martin Toul, Veronika Slonková, Jan Mičan, Sandra Thalerova, Michaela Pešková, Patrícia Kittová, Peter Scheer, Jana Hlozkova, Eliska Brhelova, Ahmet Davut Aksu, Jan Biskupič, Michaela Kuchynka, Jaroslav Ondruš, Petr Kasparek, Tereza Batkova, Martin Marek, Jan Víteček, Lukas Kubala, Robert Mikulik, Jiří Damborský, David Bednar, Zbynek Prokop

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series